Andrew Crane

M&A is a powerful strategy for organizations to acquire disruptive capabilities. Companies are using inorganic growth to catapult themselves ahead of competitors, especially in industries heavily dependent on manufacturing, such as oil and gas, and life sciences. Recent activity in life sciences includes Nestle Health Science’s acquisition of Phagenesis  and LG… read more →